We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Nuvigil and Provigil Pregnancy Registry

- Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder
- Terminated

Study Title: The Nuvigil and Provigil Pregnancy Registry

Teva Identifier: C10953/9022

ClinicalTrials.gov Identifier: NCT01792583

Study Status: Terminated

Trial Condition(s): Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder

Interventions: Drug: Modafinil/armodafinil

Study Description: The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during

Click for participation criteria and map of study locations

disease icon for clinical trials

Key Participation Requirements

Gender: Female

Age Range: Child, Adult, Older Adult

Trial Duration: June 30, 2009 - November 30, 2023

Study Type

Observational